november 07, 2023 0 27 CELEX:62023TO0222(01)_INF: Order of the President of the General Court of 21 July 2023.#Arysta Lifescience v European Food Safety Authority.#Case T-222/23 R.
julij 29, 2025 0 0 CELEX:62023TO0226(01): Order of the General Court (Fourth Chamber) of 7 February 2024.#Neuraxpharm Pharmaceuticals SL v European Commission.#Action for annulment – Medicinal products for human use – Marketing authorisation for the medicinal product Dimethyl fumarate Neuraxpharm – dimethyl fumarate – Letter of the Commission drawing conclusions from a judgment of the Court of Justice – Measure not actionable – Inadmissibility – Hypothetical acts – Manifest inadmissibility.#Case T-226/23.
april 28, 2025 0 0 CELEX:62023TO0226(01)_INF: Ordonnance du Tribunal (quatrième chambre) du 7 février 2024.#Neuraxpharm Pharmaceuticals SL contre Commission européenne.#Recours en annulation – Médicaments à usage humain – Autorisation de mise sur le marché du médicament Dimethyl fumarate Neuraxpharm - dimethyl fumarate – Lettre de la Commission tirant les conséquences d’un arrêt de la Cour – Acte non susceptible de recours – Irrecevabilité – Actes hypothétiques – Irrecevabilité manifeste.#Affaire T-226/23. This document does not exist in English.
julij 31, 2023 0 65 CELEX:62023TO0226: Order of the President of the General Court of 19 July 2023.#Neuraxpharm Pharmaceuticals SL v European Commission.#Case T-226/23 R.
september 29, 2023 0 56 CELEX:62023TO0226_INF: Order of the President of the General Court of 19 July 2023.#Neuraxpharm Pharmaceuticals SL v European Commission.#Case T-226/23 R.
julij 29, 2025 0 0 CELEX:62023TO0227(01): Order of the General Court (Fourth Chamber) of 7 February 2024.#Mylan Ireland Ltd v European Commission.#Action for annulment – Medicinal products for human use – Marketing authorisation for the medicinal product Dimethyl fumarate Mylan – dimethyl fumarate – Letter of the Commission drawing conclusions from a judgment of the Court of Justice – Measure not actionable – Inadmissibility – Hypothetical acts – Manifest inadmissibility.#Case T-227/23.
april 04, 2025 0 0 CELEX:62023TO0227(01)_INF: Ordonnance du Tribunal (quatrième chambre) du 7 février 2024.#Mylan Ireland Ltd contre Commission européenne.#Référé – Médicaments à usage humain – Autorisation de mise sur le marché – Demande de mesures provisoires – Demande d’injonction – Défaut d’urgence.#Affaire T-227/23. This document does not exist in English.
avgust 03, 2023 0 52 CELEX:62023TO0227: Order of the President of the General Court of 19 July 2023.#Mylan Ireland Ltd v European Commission.#Case T-227/23 R.
september 29, 2023 0 33 CELEX:62023TO0227_INF: Order of the President of the General Court of 19 July 2023.#Mylan Ireland Ltd v European Commission.#Case T-227/23 R.
julij 29, 2025 0 0 CELEX:62023TO0228(01): Order of the General Court (Fourth Chamber) of 7 February 2024.#Zakłady Farmaceutyczne Polpharma S.A. v European Commission.#Action for annulment – Medicinal products for human use – Marketing authorisation for the medicinal product Dimethyl fumarate Polpharma – dimethyl fumarate – Letter of the Commission drawing conclusions from a judgment of the Court of Justice – Measure not actionable – Inadmissibility – Hypothetical acts – Manifest inadmissibility.#Case T-228/23.